(1)
Finckh, A.; Kyburz, D.; Möller, B.; Schmiedel, U.; Villiger, P.; Walker, U. Swiss Consensus Statement: Recommendations for Optimising Re-Treatment With MabThera® (rituximab) in Rheumatoid Arthritis. Swiss Med Wkly 2010, 140, w13073.